These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16515116)

  • 21. Epoetin alfa treatment for acute anaemia during interferon plus ribavirin combination therapy for chronic hepatitis C.
    Bräu N
    J Viral Hepat; 2004 May; 11(3):191-7. PubMed ID: 15117320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
    Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
    Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C].
    Lee HJ; Eun JR; Choi JW; Kim KO; Moon HJ
    Korean J Hepatol; 2008 Mar; 14(1):46-57. PubMed ID: 18367857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b.
    Abergel A; Hezode C; Leroy V; Barange K; Bronowicki JP; Tran A; Alric L; Castera L; Bernard PH; Henquell C; Lafeuille H; Ughetto S; Darcha C; Chevallier M; Martineau N; Dubost S; Randl K; Dhumeaux D; Bommelaer G; Bonny C;
    J Viral Hepat; 2006 Dec; 13(12):811-20. PubMed ID: 17109680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.
    Wirth S; Pieper-Boustani H; Lang T; Ballauff A; Kullmer U; Gerner P; Wintermeyer P; Jenke A
    Hepatology; 2005 May; 41(5):1013-8. PubMed ID: 15793840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Santin M; Shaw E
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812596
    [No Abstract]   [Full Text] [Related]  

  • 27. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Picon PD; Costa AF; Kuchenbecker R; Beltrame A
    Lancet; 2002 Jan; 359(9302):263; author reply 264. PubMed ID: 11812597
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful antiviral and antituberculosis treatment with pegylated interferon-alfa and ribavirin in a chronic hepatitis C patient with pulmonary tuberculosis.
    Tsai MC; Lin MC; Hung CH
    J Formos Med Assoc; 2009 Sep; 108(9):746-50. PubMed ID: 19773215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peginterferon alfa-2b plus ribavirin for chronic hepatitis.
    Cecil BD
    Lancet; 2002 Jan; 359(9302):263-4. PubMed ID: 11812598
    [No Abstract]   [Full Text] [Related]  

  • 30. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Chen YC; Lu SN; Lin MC
    Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight-based ribavirin with pegylated interferon alfa 2b: benefits, risks, and the origin of the evidence.
    Hrachovec J; Patel P
    Gastroenterology; 2003 Jun; 124(7):2003-4; author reply 2004-5. PubMed ID: 12812198
    [No Abstract]   [Full Text] [Related]  

  • 32. Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.
    Overbeck K; Genné D; Golay A; Negro F;
    J Hepatol; 2008 Aug; 49(2):295-8. PubMed ID: 18555553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of chronic hepatitis C patients with combination of alpha-interferon and ribavirin, consensus and pegylated interferons.
    Husa P; Husova L
    Bratisl Lek Listy; 2001; 102(5):248-52. PubMed ID: 11725377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Nishiofuku M; Tsujimoto T; Matsumura Y; Toyohara M; Yoshiji H; Yamao J; Fukui H; Yoshikawa M
    Intern Med; 2006; 45(7):483-4. PubMed ID: 16679707
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous necrosis after injection of polyethylene glycol-modified interferon alfa.
    Dalmau J; Pimentel CL; Puig L; Peramiquel L; Roé E; Alomar A
    J Am Acad Dermatol; 2005 Jul; 53(1):62-6. PubMed ID: 15965422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium.
    Wong J; Nevens F
    Acta Gastroenterol Belg; 2002; 65(2):110-11. PubMed ID: 12171045
    [No Abstract]   [Full Text] [Related]  

  • 37. A 24-week pegylated interferon alpha-2b versus a 12-week pegylated interferon alpha-2b alone or with ribavirin for patients with acute hepatitis C.
    Dai CY; Chuang WL; Yu ML
    Hepatology; 2014 Dec; 60(6):2128-9. PubMed ID: 24585417
    [No Abstract]   [Full Text] [Related]  

  • 38. Local blistering reaction complicating subcutaneous injection of pegylated interferon in a patient with hepatitis C.
    Gallina K; Brodell RT; Naffah F; Nedorost S
    J Drugs Dermatol; 2003 Jan; 2(1):63-7. PubMed ID: 12852384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pityriasis rosea associated with pegylated interferon alfa and ribavirin treatment in a patient with chronic hepatitis C.
    Güner R; Keske S; Hasanoğlu I; Taşyaran M
    Balkan Med J; 2013 Jun; 30(2):253-4. PubMed ID: 25207111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute dystonia after injection of pegylated interferon alpha-2b.
    Quarantini LC; Miranda-Scippa A; Parana R; Sampaio AS; Bressan RA
    Mov Disord; 2007 Apr; 22(5):747-8. PubMed ID: 17279542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.